<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11860790</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1129</article-id><article-id pub-id-type="other">EPV0424</article-id><article-id pub-id-type="pii">S0924933824011295</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Role of Omega 3 Fatty Acid as an Adjunct Treatment to Depression in Different Age Groups of the Patient Population - A Current Literature Review</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Poudel</surname><given-names>S.</given-names></name><xref rid="aff2546" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor0985" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Dhawan</surname><given-names>A.</given-names></name><xref rid="aff2547" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Vijayakumar</surname><given-names>V.</given-names></name><xref rid="aff2548" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Flores</surname><given-names>S.</given-names></name><xref rid="aff2549" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Abozaid</surname><given-names>A.</given-names></name><xref rid="aff2550" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Parajuli</surname><given-names>K.</given-names></name><xref rid="aff2546" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Aggarwal</surname><given-names>R.</given-names></name><xref rid="aff2546" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Sadana</surname><given-names>A.</given-names></name><xref rid="aff2551" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kumar</surname><given-names>H.</given-names></name><xref rid="aff2552" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Choudhari</surname><given-names>J.</given-names></name><xref rid="aff2546" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Panta</surname><given-names>N.</given-names></name><xref rid="aff2553" ref-type="aff">
<sup>8</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ahmed</surname><given-names>S. S.</given-names></name><xref rid="aff2546" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff2546"><sup>1</sup>Department of Research &#x00026; Academic Affairs, <institution>Larkin Community Hospital</institution>, <city>South Miami</city>, <country>United States</country></aff><aff id="aff2547"><sup>2</sup><institution>Gian Sagar medical College</institution>, <city>Patiala</city>, <country>
India</country></aff><aff id="aff2548"><sup>3</sup><institution>American University of Barbados</institution>, <city>St. Micheal</city>, <country>Barbados</country></aff><aff id="aff2549"><sup>4</sup><institution>University of Medicine &#x00026; Health Sciences</institution>, <city>St. Kitts &#x00026; Nevis</city>, <country>American Samoa</country></aff><aff id="aff2550"><sup>5</sup>Faculty of Medicine, <institution>Tanta University</institution>, <city>Tanta</city>, <country>Egypt</country></aff><aff id="aff2551"><sup>6</sup><institution>Adesh Institute of Medical Science and Research</institution>, <city>Bhatinda</city>, <country>
India</country></aff><aff id="aff2552"><sup>7</sup><institution>Dow University of Health Sciences</institution>, <city>Karachi</city>, <country>
Pakistan</country></aff><aff id="aff2553"><sup>8</sup><institution>Kathmandu Medical College</institution>, <city>Kathmandu</city>, <country>Nepal</country></aff><author-notes><corresp id="cor0985"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1104">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S544</fpage><lpage>S544</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824011295a.pdf"/><abstract><sec id="sec5922"><title>Introduction</title><p>Depression is a widespread problem that affects individuals of all ages. This study looks at the use of omega-3 polyunsaturated fatty acids (PUFAs) as an additional therapy for depression in people of different ages. Depression has an impact on everyone, from youth to the elderly, causing therapeutic concerns such as treatment resistance and recurrence. Omega-3 PUFAs, which may be found in fish and flaxseed, are important because of their impact on neurochemistry, inflammation, and neuroprotection. While pharmacotherapy, including antidepressants, has proven beneficial for many, the likelihood of remission and recurrence remains substantial. In recent years, there has been a growing interest in the potential role of omega-3 polyunsaturated fatty acids (n-3 PUFAs) in mitigating depressive symptoms. The primary constituents of n-3 PUFAs are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Understanding the potential of omega-3 PUFAs across the lifespan can help address the multifaceted challenges posed by depression and improve mental health outcomes for diverse age groups.</p></sec><sec id="sec5923"><title>Objectives</title><p>This review aims to assess the role of omega-3 fatty acids in depression treatment across different age groups: children and adolescents, adults (18&#x02013;60), and the elderly (60+). It investigates the effectiveness and potential differences in omega-3 supplementation among these age cohorts.</p></sec><sec id="sec5924"><title>Methods</title><p>A comprehensive literature search was conducted from 2003 to 2023 using PubMed, Google Scholar, and EMBASE, using specific keywords. Studies with inadequate age group information or Omega-3 intervention were excluded.</p></sec><sec id="sec5925"><title>Results</title><p>
In children and adolescents, several studies indicate a positive association between omega-3 supplementation and improved depressive symptoms. In adults, results are mixed, with some studies showing benefits while others do not. In the elderly, omega-3 PUFAs appear to have a more consistent positive effect on depression. In contrast, a consistent positive association was observed in the geriatric population, suggesting that Omega-3 PUFAs may hold particular promise in the treatment of depression among older adults. However, variations in methodology, dosage, and study populations contribute to these mixed findings.</p></sec><sec id="sec5926"><title>Conclusions</title><p>Omega-3 PUFAs show promise as an adjunct therapy for depression across different age groups. Further research with standardized methodologies and larger sample sizes is needed to clarify their role and establish optimal dosage guidelines. Omega-3 PUFAs should be considered as a potential complement to conventional depression treatments, emphasizing the need for personalized approaches in depression management.</p></sec><sec id="sec5927"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>